These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 22399617)
1. Integrated genomic characterization of the kallikrein gene locus in cancer. Girgis AH; Bui A; White NM; Yousef GM Anticancer Res; 2012 Mar; 32(3):957-63. PubMed ID: 22399617 [TBL] [Abstract][Full Text] [Related]
2. Parallel overexpression of seven kallikrein genes in ovarian cancer. Yousef GM; Polymeris ME; Yacoub GM; Scorilas A; Soosaipillai A; Popalis C; Fracchioli S; Katsaros D; Diamandis EP Cancer Res; 2003 May; 63(9):2223-7. PubMed ID: 12727843 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of kallikrein-related peptidases: there is a whole new world out there. Pasic MD; Olkhov E; Bapat B; Yousef GM Biol Chem; 2012 Apr; 393(5):319-30. PubMed ID: 22505515 [TBL] [Abstract][Full Text] [Related]
4. Predictions for the future of kallikrein-related peptidases in molecular diagnostics. Scorilas A; Mavridis K Expert Rev Mol Diagn; 2014 Jul; 14(6):713-22. PubMed ID: 24927162 [TBL] [Abstract][Full Text] [Related]
6. Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies. Avgeris M; Mavridis K; Scorilas A Biol Chem; 2010 May; 391(5):505-11. PubMed ID: 20302518 [TBL] [Abstract][Full Text] [Related]
7. A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus. Kaushal A; Myers SA; Dong Y; Lai J; Tan OL; Bui LT; Hunt ML; Digby MR; Samaratunga H; Gardiner RA; Clements JA; Hooper JD Prostate; 2008 Mar; 68(4):381-99. PubMed ID: 18196551 [TBL] [Abstract][Full Text] [Related]
8. Human tissue kallikreins: the cancer biomarker family. Paliouras M; Borgono C; Diamandis EP Cancer Lett; 2007 Apr; 249(1):61-79. PubMed ID: 17275179 [TBL] [Abstract][Full Text] [Related]
9. Human kallikrein-related peptidase 12: antibody generation and immunohistochemical localization in prostatic tissues. Memari N; Diamandis EP; Earle T; Campbell A; Van Dekken H; Van der Kwast TH Prostate; 2007 Sep; 67(13):1465-74. PubMed ID: 17654496 [TBL] [Abstract][Full Text] [Related]
10. Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies. Yousef GM; Magklara A; Chang A; Jung K; Katsaros D; Diamandis EP Cancer Res; 2001 Apr; 61(8):3425-31. PubMed ID: 11309303 [TBL] [Abstract][Full Text] [Related]
11. Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers. Kontos CK; Scorilas A Clin Chem Lab Med; 2012 Nov; 50(11):1877-91. PubMed ID: 23093268 [TBL] [Abstract][Full Text] [Related]
12. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker. Yousef GM; Kyriakopoulou LG; Scorilas A; Fracchioli S; Ghiringhello B; Zarghooni M; Chang A; Diamandis M; Giardina G; Hartwick WJ; Richiardi G; Massobrio M; Diamandis EP; Katsaros D Cancer Res; 2001 Nov; 61(21):7811-8. PubMed ID: 11691797 [TBL] [Abstract][Full Text] [Related]
13. Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies. Dorn J; Bayani J; Yousef GM; Yang F; Magdolen V; Kiechle M; Diamandis EP; Schmitt M Thromb Haemost; 2013 Sep; 110(3):408-22. PubMed ID: 23765253 [TBL] [Abstract][Full Text] [Related]
14. Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevance. Avgeris M; Mavridis K; Scorilas A Biol Chem; 2012 Apr; 393(5):301-17. PubMed ID: 22505514 [TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysis. Kountourakis P; Psyrri A; Scorilas A; Markakis S; Kowalski D; Camp RL; Diamandis EP; Dimopoulos MA Thromb Haemost; 2009 Mar; 101(3):541-6. PubMed ID: 19277417 [TBL] [Abstract][Full Text] [Related]
16. Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers. Emami N; Diamandis EP Clin Chem; 2008 Oct; 54(10):1600-7. PubMed ID: 18687738 [TBL] [Abstract][Full Text] [Related]
17. A computational analysis of the genetic and transcript diversity at the kallikrein locus. Lai J; An J; Srinivasan S; Clements JA; Batra J Biol Chem; 2016 Dec; 397(12):1307-1313. PubMed ID: 27289002 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the human kallikrein gene 15 expression in ovarian cancer. Yousef GM; Scorilas A; Katsaros D; Fracchioli S; Iskander L; Borgono C; Rigault de la Longrais IA; Puopolo M; Massobrio M; Diamandis EP J Clin Oncol; 2003 Aug; 21(16):3119-26. PubMed ID: 12915603 [TBL] [Abstract][Full Text] [Related]
19. Mining human cancer datasets for kallikrein expression in cancer: the 'KLK-CANMAP' Shiny web tool. Wang C; Moya L; Clements JA; Nelson CC; Batra J Biol Chem; 2018 Sep; 399(9):983-995. PubMed ID: 30052511 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of kallikrein-related peptidases in the normal kidney and renal tumors: potential clinical implications. Gabril M; White NM; Moussa M; Chow TF; Metias SM; Fatoohi E; Yousef GM Biol Chem; 2010 Apr; 391(4):403-9. PubMed ID: 20128686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]